Professional Documents
Culture Documents
Mood disorders and conditions of impaired or diminished cognition affect more than one in every four persons in
the developed world. According to the Diagnostic and Statistical Manual of Mental Disorders, four out of the 10
leading causes of disability in the US and other developed countries are mental disorders. The principal clinical
manifestations of mood disorders include personality change, depression, agitation, aggression, addiction and
anxiety. The major cognitive disorders are dementia and Alzheimer's disease, both of which are increasing at an
unprecedented rate worldwide. In moderate to serious cases, these afflictions are every bit as debilitating as
cancer or heart disease. In fact, in the UK, 92% of hospital consultations for mood disorders require hospital
admission; women constitute about 60% of these patients.
Hormones vary in their intensity and effects with time. Consequently, men and women experience depression at
different times in their lives. Men and women also differ in their experience of mood disorders and their response
to antidepressants. Males tend to display more discernable symptoms of depression, including anger and
restlessness whereas women tend to suffer the disease in relative silence. Societal attitudes towards these
diseases have been slow to change. In the US, South America, Africa and Asia, many people still attach a moral
stigma to mental illness. This mindset can seriously undermine the allocation of sufficient resources and
attention to the need for treatment and a better popular and scientific understanding and diagnosis of these
conditions. It has only been a few decades since the mentally ill were routinely packed off to dismal state-run
institutions that did little more than deeply sedate them and provide minimal care and attention.
The current emphasis on pharmaceutical drugs as the preferred treatment option has failed both society and
those afflicted with these disorders. If it is true, and evidence supports this assumption, that factors such as diet,
Mood Health
environment, sedentary lifestyle and self-destructive habits such as smoking and binge drinking are instrumental
in causing or, at the very least, exacerbating mood and cognitive disease, it is unlikely that the answer lies in
new pharmaceutical agents or treatments. After four decades of research, no truly efficacious pharmaceutical
treatment for Alzheimer's disease or dementia has been developed — and we are only now beginning to
understand the biochemical modalities that characterize the brain of a typical Alzheimer's sufferer. Drugs do exist
that are somewhat effective in treating the more severe symptoms of depression, anxiety and bipolar disease;
yet, these are all short-term solutions whose side-effects are often as disruptive as the disease they are meant to
treat. Lithium, for example, commonly prescribed to treat bipolar disorder, must be taken in such high doses that
it causes severe adverse effects that include a dulled personality, flat lifeless emotions, memory loss, tremors or
obesity. Consequently, the patients often refuse to take this and other medications or risk drug toxicity if the dose
is not carefully monitored.
Given the enormous expense of care facilities equipped to deal with a patient suffering from such debilitating
symptoms and the lack of public financial assistance, the burden is falling on their families. Doubly troubling is
that this is happening at the very time when the children have gone off to work or university and mum and dad
were looking forward to the stage in their lives wherein they could finally enjoy the fruits of their careers. Instead,
the spectre of bankruptcy looms, as well as a fear that they themselves will soon begin to experience the
ominous early symptoms of Alzheimer's or dementia.
Nutrition
There are two essential components to a nutritional strategy. The first is to observe some general dietary
guidelines and the second is to consider some specific nutrients that may have an impact on mood and
cognition. The connection between diet and mood and cognitive disorders and the putative neuroprotective
properties of various nutrients has been well established.
General Guidelines
• Practice mild caloric restriction. Reduce the total number of carbohydrate calories consumed by about
10% without compromising general nutrition.
• Limit meat consumption to one meal per week and only consume organic, hormone- and antibiotic-free
meat if you must consume it at all.
• Make green leafy vegetables your first priority and only eat meats, grains, nuts and other foods after
eating at least one portion of green leafy veggies every day.
Mood Health
• Eliminate all foods and beverages that contain High Fructose Corn Syrup (HFCS) and limit the
consumption of all sugars to no more than 20 g/day. For sugar substitutes, consider stevia or xylitol, but
not aspartame, sorbitol or saccharin.
• Avoid all fast food franchises unless you are certain that the food offered is free from chemical additives,
extra salt, extra sugar and trans fats.
• Limit your consumption of all animal fats and dairy products to no more than 200 g/week.
• Consume primarily low glycaemic index foods for energy needs. Examples include fruit, vegetables,
wholemeal bread, beans, brown rice and nuts.
• Drink alcoholic beverages in moderation. Red wine is better than spirits but excessive alcohol is toxic …
regardless of the source.
investigated by researchers and physicians as a possible therapy to at least slow the progression of Alzheimer's
disease. Chronic inflammation is a by-product of cytotoxicity, one of the modalities that appears to characterize
the brains of Alzheimer's patients. Several epidemiological studies indicate that the moderate consumption of
wine is associated with a lower incidence of Alzheimer's disease. These findings demonstrate a proteasome-
dependent antiamyloidogenic activity of resveratrol and suggest that this natural compound has therapeutic
potential in Alzheimer's disease.